Company registration number 02648058 (England and Wales)
MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
12,031
24,339
Current assets
Debtors
4
803,801
954,906
Cash at bank and in hand
155,425
210,023
959,226
1,164,929
Creditors: amounts falling due within one year
5
(488,439)
(730,509)
Net current assets
470,787
434,420
Total assets less current liabilities
482,818
458,759
Provisions for liabilities
(2,467)
(659)
Net assets
480,351
458,100
Capital and reserves
Called up share capital
10,000
10,000
Capital redemption reserve
6,000
6,000
Other reserves
27,720
27,720
Profit and loss reserves
436,631
414,380
Total equity
480,351
458,100
MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 12 September 2025 and are signed on its behalf by:
Mr P Yeomans
Director
Company registration number 02648058 (England and Wales)
MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Medical Architecture And Art Projects Limited is a private company limited by shares incorporated in England and Wales. The registered office is 4 Northington Street, London, England, WC1N 2JG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to time spent, skills and expertise provided and expenses incurred, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
Straight line over life of lease
Fixtures and fittings
20% on reducing balance
Computers
Straight line over 3 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

1.7
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
31
35
MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Tangible fixed assets
Leasehold land and buildings
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 April 2024
92,449
173,833
470,854
737,136
Additions
-
0
-
0
4,226
4,226
At 31 March 2025
92,449
173,833
475,080
741,362
Depreciation and impairment
At 1 April 2024
83,166
168,891
460,740
712,797
Depreciation charged in the year
9,283
988
6,263
16,534
At 31 March 2025
92,449
169,879
467,003
729,331
Carrying amount
At 31 March 2025
-
0
3,954
8,077
12,031
At 31 March 2024
9,283
4,942
10,114
24,339
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
445,472
670,914
Corporation tax recoverable
54,093
11,024
Amounts owed by group undertakings
212,083
8,593
Other debtors
25,551
19,842
Prepayments and accrued income
66,602
244,533
803,801
954,906
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
-
0
4,479
Obligations under finance leases
-
0
66,416
Trade creditors
128,116
347,084
Taxation and social security
196,915
145,073
Other creditors
65,654
66,487
Accruals and deferred income
97,754
100,970
488,439
730,509
MEDICAL ARCHITECTURE AND ART PROJECTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
6
Parent company

The ultimate parent of the company is Medical Architecture Holdings Limited, a company incorporated in England and Wales.

2025-03-312024-04-01falsefalsefalse12 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr R F ReevesMr R WillsMr P YeomansMrs L C Knotts026480582024-04-012025-03-31026480582025-03-31026480582024-03-3102648058core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-03-3102648058core:FurnitureFittings2025-03-3102648058core:ComputerEquipment2025-03-3102648058core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-03-3102648058core:FurnitureFittings2024-03-3102648058core:ComputerEquipment2024-03-3102648058core:ShareCapital2025-03-3102648058core:ShareCapital2024-03-3102648058core:CapitalRedemptionReserve2025-03-3102648058core:CapitalRedemptionReserve2024-03-3102648058core:OtherMiscellaneousReserve2025-03-3102648058core:OtherMiscellaneousReserve2024-03-3102648058core:RetainedEarningsAccumulatedLosses2025-03-3102648058core:RetainedEarningsAccumulatedLosses2024-03-3102648058bus:Director32024-04-012025-03-3102648058core:LandBuildingscore:LongLeaseholdAssets2024-04-012025-03-3102648058core:FurnitureFittings2024-04-012025-03-3102648058core:ComputerEquipment2024-04-012025-03-31026480582023-04-012024-03-3102648058core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-03-3102648058core:FurnitureFittings2024-03-3102648058core:ComputerEquipment2024-03-31026480582024-03-3102648058core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-04-012025-03-3102648058core:CurrentFinancialInstruments2025-03-3102648058core:CurrentFinancialInstruments2024-03-3102648058bus:PrivateLimitedCompanyLtd2024-04-012025-03-3102648058bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3102648058bus:FRS1022024-04-012025-03-3102648058bus:AuditExemptWithAccountantsReport2024-04-012025-03-3102648058bus:Director12024-04-012025-03-3102648058bus:Director22024-04-012025-03-3102648058bus:Director42024-04-012025-03-3102648058bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP